Latest papers

Where to go next with neuroprotection in multiple sclerosis?

The efficacy of motor-evoked potentials on cerebral aneurysm surgery and new-onset postoperative motor deficits.

From the archives. Corticobasal degeneration. By WRG Gibb, PJ Luther and CD Marsden. Brain 1989: 112; 1171-1192 with Corticobasal degeneration. A clinical study of 36 cases. By JO Rinne, MS Lee, PD Thompson and CD Marsden. Brain 1994: 117; 1183-1196.

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

[Relationship of motor deficits and imaging features in metastatic epidural spinal cord compression].

Protective role of aquaporin-4 water channels after contusion spinal cord injury.

The relevance of clinical balance assessment tools to differentiate balance deficits.

Expertise with pathological actions modulates a viewer's motor system.

Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression

[American Academy of Neurology, Toronto, April 10-7, 2010].

Anxiety and depression in psychogenic movement disorder and non-epileptic seizures: a prospective comparative study.

Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia.

Recent skin injuries in children with motor disabilities.

Semi-dominant X-chromosome linked learning disability with progressive ataxia, spasticity and dystonia associated with the novel MECP2 variant p.V122A: akin to the new MECP2 duplication syndrome?

Screening for MAPT and PGRN mutations in Korean patients with PSP/CBS/FTD.

Unilateral carotid granulomatous arteritis and Crohn's disease.

Myelopathy hand: new evidence of the classical sign.

Beta-band oscillations--signalling the status quo?

Adverse effects of antipsychotic medications.

Low bone mass in patients with motor disability: prevalence and risk factors in 59 Finnish children.